How about hospital records and a Pfizer

New Post Public Reply Private Reply Replies (2) Message Board
Rusty Bhawks #76163
257
How about hospital records and a Pfizer admission?

Pfizer logs 1,223 deaths, 42,086 adverse reactions after just three months of vaccine rollout

I n a stunning “confession,” Pfizer admitted that it has logged a staggering 42,086 adverse reactions – representing a total of 158,893 adverse events – in the first three months of its vaccine rollout. Over 25,000 of the reported events were classified as “nervous system disorders.”

The pharmaceutical giant also listed 1,223 deaths over the same period, which should be enough cause to stop the vaccination program.


That confession can be found in the first batch of documents released by the Food and Drug Administration (FDA) in accordance with a Freedom of Information Act (FOIA) lawsuit by the Public Health and Medical Professionals for Transparency (PHMT). (

In his blog at Global Research, Jon Rappoport said that the appendix of the Pfizer document is the most astonishing section because it listed all the types of adverse reactions reported within just three months of vaccinations.

Investigative journalist Celia Farber listed the adverse reactions culled from the documents, including acute respiratory distress syndrome, pneumonia, Stevens-Johnson syndrome, dermatitis, Bell’s Palsy, skin allergies, paralysis, kidney and liver problems and other life-threatening side effects.

While praising Farber for her input, Rappoport said the public must resist and rebel no matter what. ”These are the stakes. This is the war,” he wrote.

Experimental mRNA vaccines never been used before pandemic.

The mRNA vaccine produced by both Pfizer and Moderna is a completely new type of vaccine that has never been licensed or used on humans before the Wuhan coronavirus (COVID-19) pandemic.

As such, nobody has any idea what to expect from this type of vaccine.

Traditional vaccines introduce pieces of a weakened virus to stimulate an immune response, while mRNA vaccines inject molecules of synthetic genetic material from non-human sources into your cells – thus hijacking your genes and permanently reprogramming them to produce antibodies to kill SARS-CoV-2, the virus causing COVID-19.

The mRNA vaccines of Moderna and Pfizer could barely be regarded as medicine in the traditional sense. They are transhumanistic tools to synthetically alter you at the genetic level.

Vaccines usually take seven to 20 years to adequately research, test and bring to market.

The slew of COVID vaccines produced by Big Pharma companies were rushed to market in less than 12 months, which is nowhere enough time to meet established safety standards.

No long-term safety studies were conducted, so no one has any real idea of the danger these vaccines could cause down the line.

It is not an understatement when people say that much of the worldwide population has become Big Pharma’s guinea pigs. (Related: Pfizer, FDA know the COVID vaccine is dangerous, but they push it anyway)

The COVID vaccines promote disease enhancement due to pathogenic priming. In other words, they make people sicker than the disease would have. These mRNA vaccines are only designed to stop mild symptoms.

These vaccines are also not designed to stop transmission. Big Pharma companies admitted they didn’t design the vaccine to stop transmission. Therefore, vaccinated individuals can still transmit the virus to others – vaccinated or not.

The mRNA vaccines will not be truly effective since they were not based on an actual isolated sample of the SARS-CoV-2 virus. The World Health Organization (WHO) has admitted there was no evidence the vaccines were effective.

WHO chief scientist Soumya Swaminathan Yadav said there is no evidence to suggest that the COVID vaccines can prevent people from getting COVID-19 or passing it on to others.

https://sciencefraud.news/2021-12-14-pfizer-l...tions.html
Scroll down for more posts ▼

Top 10 Most Recent News Articles

New Era Celebrates Valkyries' Groundbreaking WNBA Win

Updated Category News Views 128

A Surprising Win for a Rising Team In the world of sports, sometimes the odds are defied, and stories of triumph unfold that capture the imagination. The Golden State Valkyries did exactly that by snagging their first WNBA Championship title just a year after entering the league. It's a narrative right out of a Hollywood script—only this time, it's inked in real...

Continue Reading
Tenax Therapeutics Faces Class Action Amid Massive Loss

Updated Category News Views 188

Investors Eye Deadline Amidst Legal Storm Holy moly, Tenax Therapeutics is caught with their pants down—and we're not talking loose change. Any sorry soul who bought into Tenax's promises about their TNX-103 drug is now staring down a high-stakes class action lawsuit. If you were holding on to those dreams turned nightmares between November 13, 2023, and August 7, 2026,...

Continue Reading
Nicely Network: Top Reddit Marketing for Big Brands

Updated Category News Views 166

Reddit and AI: Nicely Network's Winning Formula Straight out of New York comes the latest scoop: Nicely Network's been crowned king of the Reddit jungle, earning the title of Best Reddit Marketing Agency for Enterprise Brands this November, courtesy of Better Business Advice. Now, if you've been paying any attention to how brands are grappling with the impossible search...

Continue Reading
AppLovin Faces Lawsuit Over AI Revenue Claims

Updated Category News Views 17

AppLovin’s Alleged Missteps: Investors Speak Up Earlier this year, folks holding AppLovin shares were sold a story of grand ambitions. The company's focus was on the promise of AI—dreams of skyrocketing revenue through innovative tools and self-service platforms. But as those promises struggled to take shape, investors pulled back the curtain, and the legal eagles...

Continue Reading
Virtual K-Pop Takes U.S. by Storm: HYPEVERSE Emerges

Updated Category News Views 194

The Rise of Virtual K-Pop Across the Atlantic It's a bold new world for K-pop, and HYPEVERSE is leading the charge. Forget the typical idol group—this one's pulling out all the stops by going virtual and zeroing in on American audiences. Now, as someone who's been burned by the volatility of music stocks in the past, I'm peering at this development with a mix of...

Continue Reading
Ensuring Flooring Stability: Acclimation's Key Role

Updated Category News Views 191

Dive into the World of Flooring Acclimation You ever hear about flooring acclimation? Sounds as riveting as watching paint dry, right? But Austin J. Messina from Salem, New Hampshire, is here to tell us it's the secret to flooring that doesn't buckle under pressure—literally. Messina's insights, splashed across the pages of HelloNation, delve deep into the nitty-gritty...

Continue Reading
Chiropractic Insights: Differentiating Piriformis vs. Disc Pain

Updated Category News Views 173

Understanding Pain: Two Paths, One Problem Buttock and leg pain is a real drag, isn't it? We often brush it off as sciatica, but here's a twist: it might not be the usual corporate villain—a herniated disc. Instead, we could be dealing with an underdog called piriformis syndrome. According to Dr. Mitch Quill, D.C., of HelloNation fame, understanding these nuances isn't...

Continue Reading
Orthocell's Remplir™ Hits Record U.S. Sales in October

Updated Category News Views 92

Orthocell's October Surprise with Remplir™ Sales Well, isn't this a breath of fresh air? Orthocell Limited just reported a staggering rise in its U.S. Remplir™ sales for October 2026. We're talking 92 units shifting off the shelves, pulling in a tidy AU$279,000. That's an 84% leap compared to the average monthly sales of 50 units in Q1 FY27. It seems the company's...

Continue Reading
TESSAN and Jamie Leibert's Daring Alpine Documentary Launch

Updated Category News Views 273

Steps Beyond the Obvious Adventure Launching headlong into the unknown—literally and figuratively—is what the documentary Jump Into The Unknown captures. TESSAN and Jamie Leibert have peeled back the curtain on adventure, showing us that it’s not just about the destination, but every twist, turn, and recalibrated step in between. The Backstory Behind Every Jump...

Continue Reading
XPeng Hits New Monthly Delivery Record in October

Updated Category News Views 304

XPeng Smashes Delivery Records Yet Again Ah, the green light’s on for XPeng, and it's a bright one! This October, we learned that XPeng hit the throttle hard with a new record of 50,237 vehicles delivered. Now, that's a sizable rally—a 22% climb month-over-month and shooting 20% higher than last October. For a company like XPeng, which resembles a bulldog with its...

Continue Reading

Top 5 Most Recently Viewed Articles

Cumberland Pharmaceuticals Plans Q3 2024 Financial Update Soon

Updated Category News Views 119

Cumberland Pharmaceuticals Set to Announce Q3 2024 Results Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX), a specialty pharmaceutical company, is gearing up to disclose its financial performance for the third quarter of 2024. This event will take place following the market's closure on a designated Thursday in November, allowing stakeholders to gain insight into the...

Continue Reading
Halliburton's Q2 Performance: CEO Warns of Market Challenges

Updated Category News Views 156

Halliburton's Recent Performance Overview Halliburton Co. (NYSE: HAL) recently reported second-quarter earnings that surpassed revenue estimates while aligning with earnings expectations. Despite this promising financial report, shares traded lower, reflecting concerns stemming from CEO Jeff Miller's cautious outlook regarding the short-term oilfield services market....

Continue Reading
Urgent Need for Debt Ceiling Action as Government Funds Dwindle

Updated Category News Views 396

Urgent Need for Debt Ceiling Action The United States is at a critical juncture as Treasury Secretary Janet L. Yellen has stated that the government has less than three weeks to address its debt limit. Her announcement emphasizes the urgency of Congressional intervention. The Implications of Not Raising the Debt Limit Yellen conveyed her concerns through a letter to...

Continue Reading
Scenthound Highlights Importance of Pet Dental Care Month

Updated Category News Views 130

Scenthound Highlights Importance of Pet Dental Care Month Nation's Leading Dog Wellness Franchise Champions Pet Health through Education, Services, and Innovative Products As we dive into the dedicated celebration of Pet Dental Health Month, Scenthound is at the forefront of emphasizing the essential role dental hygiene plays in the health of dogs. The franchise aims to...

Continue Reading
Charles Cynamon's Leadership Role at Telesat Government Solutions

Updated Category News Views 119

Charles Cynamon Takes the Helm at Telesat Government Solutions OTTAWA, Ontario and ARLINGTON, Va. – Telesat (NASDAQ and TSX: TSAT), a prominent player in the satellite industry, has appointed Charles "Chuck" Cynamon as President of Telesat Government Solutions. This division, dedicated to providing secure satellite solutions for U.S. Government civil, military, and...

Continue Reading